Home LiteratureArticle Details
PMID: 17145808 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma.

Lee TK, Poon RT, Yuen AP, Ling MT, Wang XH, Wong YC, Guan XY, Man K, Tang ZY, Fan ST

Abstract

Metastasis is commonly associated with poor prognosis of hepatocellular carcinoma (HCC). Being an important angiogenic factor, vascular endothelial growth factor (VEGF) plays a central role in HCC growth and metastasis. Recently, Id-1 (inhibitor of differentiation/DNA synthesis) has been suggested to be a key factor in cancer progression but the molecular mechanism remains unknown. We first showed that overexpression of Id-1 was correlated with HCC metastasis (P < 0.001) and its expression was significantly correlated with VEGF expression by tissue microarray. By ectopic transfection of Id-1 into HCC cells, Id-1 was able to induce VEGF secretion through activation of VEGF transcription. Increased VEGF secretion in Id-1 transfectants induced morphologic change and proliferation of human umbilical vascular endothelial cell resulting in promotion of angiogenesis. Id-1 induced transcriptional activation of VEGF by stabilizing hypoxia-inducible factor-1alpha protein. Down-regulation of Id-1 by antisense approach led to suppression of hypoxia-inducible factor-1alpha-mediated VEGF production. In addition, Id-1 suppression resulted in retardation of cell invasion through down-regulation of VEGF. Id-1 is a novel angiogenic factor for HCC metastasis and down-regulation of Id-1 may be a novel target to inhibit HCC metastasis through suppression of angiogenesis.

MeSH Terms
Animals Carcinoma, Hepatocellular/drug therapy,physiopathology,secondary Cell Line, Tumor Cell Proliferation/drug effects Down-Regulation/drug effects Endothelial Cells/drug effects Gene Expression Profiling Humans Hypoxia-Inducible Factor 1, alpha Subunit/metabolism Inhibitor of Differentiation Protein 1/antagonists & inhibitors,genetics,metabolism Liver Neoplasms/drug therapy,physiopathology,secondary Mice Mice, Nude Neovascularization, Pathologic/metabolism Oligodeoxyribonucleotides, Antisense/pharmacology,therapeutic use Reverse Transcriptase Polymerase Chain Reaction Structure-Activity Relationship Tissue Array Analysis Transplantation, Heterologous Vascular Endothelial Growth Factor A/genetics,metabolism Xenograft Model Antitumor Assays
Chemicals
Hypoxia-Inducible Factor 1, alpha Subunit Inhibitor of Differentiation Protein 1 Oligodeoxyribonucleotides, Antisense Vascular Endothelial Growth Factor A
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Lee Terence K
Department of Surgery, The University of Hong Kong, Hong Kong, China.
Poon Ronnie T P
Yuen Anthony P
Ling Ming Tat
Wang Xiang Hong
Wong Yong Chuan
Guan Xin Yuan
Man Kwan
Tang Zao You
Fan Sheung Tat
Article Info
Journal
Clinical cancer research : an official journal of the American Association for Cancer Research
Abbr.
Clin Cancer Res
ISSN
1078-0432
Published
2006-12-01
Pages
6910-9
Language
English
Region
United States
NLM ID
9502500
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com